Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 

    2023     2022  
    December 31,  
    2023     2022  
Common stock warrants August 2021     112,429       128,500  
Underwriter warrants August 2021     2,287       2,287  
Private warrants           90  
Chanticleer warrants     57       57  
Series C warrants     18,391       36,778  
Series 3 warrants     12,548       12,548  
Unvested restricted stock units and awards     7,840       10,002  
Common stock warrants February 2023     271,883        
Underwriter warrants February 2023     15,466        
Common stock private placement warrants June 2023     227,272        
Placement agent warrants June 2023     6,818        
Common stock warrants October 2023     5,687,500        
Underwriter warrants October 2023     85,312        
Total anti-dilutive weighted average shares     6,447,803       190,262